Arctic
Invent
Case Registry
Dashboard
Case Explorer
Back to Explorer
Update Case Entry
Manually curate individual case documents inside the PostgreSQL engine.
Case Lawsuit Title
*
Case / Trial ID Number
Jurisdiction Code
*
us
in
upc
eu
Category
*
Patent
Trademark
Copyright
Design
Filing Date
Decision Verdict Date
Court / Tribunal
Bench / Panel Judges
Petitioner / Claimant (Plaintiff)
Glaxo Group Limited
Respondent / Defendant
Maiden Pharmaceuticals Limited
Dispute Summary
The Delhi High Court addressed an application seeking interim injunctive relief regarding trademark infringement in the pharmaceutical sector. The court found prima facie substance in Glaxo Group Limited's claim against Maiden Pharmaceuticals Limited concerning the marks BETNOMAID and MEDNOVATE, ruling that these were deceptively similar to the plaintiff's registered trademarks (BETNESOL/BETNOVATE). Consequently, an injunction was granted restraining the defendant from using these specific marks pending the final suit. However, the court declined to grant an injunction against the mark BETASON.
Outcome / Ruling
mixed
Verdict Document PDF URL
Full text judgment
Cancel
Update Case